Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

LQDA

Liquidia Corp

Apr 23 • 04:00PM ET

12.95

Dollar change -0.23
Percentage change -1.75	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO DWAS VTWO PTH VHT IWN IWC

Index	RUT	P/E	-	EPS (ttm)	-1.21	Insider Own	26.73%	Shs Outstand	68.63M	Perf Week	-4.64%
Market Cap	984.59M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	7.66%	Shs Float	55.70M	Perf Month	-22.59%
Income	-78.50M	PEG	-	EPS next Q	-0.32	Inst Own	47.14%	Short Float	13.34%	Perf Quarter	5.71%
Sales	17.49M	P/S	56.29	EPS this Y	5.30%	Inst Trans	-4.06%	Short Ratio	8.35	Perf Half Y	110.06%
Book/sh	0.69	P/B	18.79	EPS next Y	54.07%	ROA	-62.36%	Short Interest	7.43M	Perf Year	86.60%
Cash/sh	1.10	P/C	11.77	EPS next 5Y	-	ROE	-114.01%	52W Range	5.71 - 16.99	Perf YTD	7.65%
Dividend Est.	-	P/FCF	-	EPS past 5Y	30.44%	ROI	-158.09%	52W High	-23.78%	Beta	0.24
Dividend TTM	-	Quick Ratio	4.85	Sales past 5Y	423.30%	Gross Margin	76.18%	52W Low	126.80%	ATR (14)	0.77
Dividend Ex-Date	-	Current Ratio	4.85	EPS Y/Y TTM	-73.00%	Oper. Margin	-419.62%	RSI (14)	34.54	Volatility	5.59% 5.49%
Employees	136	Debt/Eq	0.07	Sales Y/Y TTM	9.75%	Profit Margin	-448.89%	Recom	1.57	Target Price	23.86
Option/Short	Yes / Yes	LT Debt/Eq	0.05	EPS Q/Q	-314.22%	Payout	-	Rel Volume	1.31	Prev Close	13.18
Sales Surprise	-4.30%	EPS Surprise	-81.66%	Sales Q/Q	-15.47%	Earnings	Mar 13 BMO	Avg Volume	890.09K	Price	12.95
SMA20	-11.81%	SMA50	-11.78%	SMA200	31.85%	Trades		Volume	1,162,072	Change	-1.75%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-24	Reiterated	Needham	Buy	$18 → $28
Sep-19-22	Resumed	Wedbush	Underperform	$3
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform	$3
Jul-22-22	Initiated	Ladenburg Thalmann	Buy	$15
May-31-22	Initiated	BTIG Research	Buy	$14
May-26-22	Initiated	BofA Securities	Buy	$12
Dec-04-20	Initiated	H.C. Wainwright	Buy	$6
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral	$20 → $4
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform	$26
Aug-20-18	Initiated	Needham	Buy	$30
Aug-20-18	Initiated	Jefferies	Buy	$22

Show Previous Ratings

Apr-02-24 09:00AM	Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-01-24 06:00AM	Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA (treprostinil) inhalation powder (GlobeNewswire)
Mar-20-24 01:50AM	Chief Medical Officer Rajeev Saggar Sells Shares of Liquidia Corp (LQDA) (GuruFocus.com)
01:49AM	Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA) (GuruFocus.com)
Mar-16-24 02:42PM	Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:54PM	Loading…
Mar-13-24 10:54PM	Q4 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents) +5.36%
07:31AM	Liquidia Corp (LQDA) Reports Full Year 2023 Financial Results (GuruFocus.com)
07:10AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:00AM	Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-06-24 06:30AM	Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024 (GlobeNewswire)
Feb-21-24 03:17PM	United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings (Benzinga)
06:51AM	UPDATE 3-United Therapeutics starts litigation with FDA over rival Liquidia's drug application (Reuters)
06:24AM	United Therapeutics, in unusual step, sues FDA over rivals drug application (BioPharma Dive)
Jan-30-24 06:30AM	Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress (GlobeNewswire)
Jan-29-24 09:55AM	Wall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 71.41%: Read This Before Placing a Bet (Zacks)
06:25AM	Loading…
Jan-25-24 06:25AM	UPDATE 1-US FDA still reviewing Liquidia's inhaled blood pressure drug (Reuters)
06:00AM	Liquidia Corporation Provides Update on New Drug Application for YUTREPIA (treprostinil) inhalation powder (GlobeNewswire)
Jan-19-24 06:30AM	Liquidia Corporation Announces Updates to Operations Leadership (GlobeNewswire)
Jan-09-24 06:21PM	Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 29.94%: Here's is How to Trade (Zacks)
04:56PM	What Makes Liquidia Technologies, Inc. (LQDA) a Strong Momentum Stock: Buy Now? (Zacks)
Jan-08-24 08:22AM	Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims (GlobeNewswire)
Jan-05-24 06:45AM	Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD (GlobeNewswire)
Jan-04-24 09:10AM	Liquidia Corporation Announces $100 Million in New Financings (GlobeNewswire) +7.97%
Jan-02-24 06:45AM	Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-23 06:45AM	16 Most Promising Long-Term Stocks According to Analysts (Insider Monkey)
Dec-25-23 08:00AM	Biotech CEOs Are Buying Up Their Surging Stocks (Barrons.com)
Dec-22-23 06:35PM	Peabody Energy, Janus International, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-20-23 04:56PM	U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent) (GlobeNewswire) +35.70%
Dec-19-23 01:02PM	Insider Sell Alert: Chief Medical Officer Rajeev Saggar Sells 14,887 Shares of Liquidia Corp (LQDA) (GuruFocus.com) +5.63%
Dec-12-23 07:13AM	Liquidia Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
10:47AM	Loading…
Nov-08-23 10:47AM	Liquidia Corporation (NASDAQ:LQDA) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:44AM	Q3 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-07-23 07:07AM	Liquidia Corp (LQDA) Reports Q3 2023 Financial Results (GuruFocus.com)
06:30AM	Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-31-23 06:30AM	Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023 (GlobeNewswire)
Oct-02-23 07:00AM	Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors (GlobeNewswire)
Sep-25-23 04:09PM	FDA Accepts Submission to Add PH-ILD to YUTREPIA Label (GlobeNewswire)
Sep-06-23 04:30PM	United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office (GlobeNewswire)
Aug-13-23 05:22AM	Liquidia Corporation (NASDAQ:LQDA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-11-23 12:38AM	Q2 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents) -9.13%
Aug-10-23 07:15AM	Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:00AM	Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-03-23 08:17AM	Liquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023 (GlobeNewswire)
Jul-27-23 09:13AM	Liquidia Stock Down 12% But Insiders Still In US$74k Profit (Simply Wall St.)
06:00AM	Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA (treprostinil) Inhalation Powder (GlobeNewswire)
Jul-25-23 02:37PM	Liquidia stock drops after setback in United Therapeutics dispute (American City Business Journals)
08:25AM	Silver Spring's United Therapeutics claims victory in patent infringement suit against Liquidia (American City Business Journals)
Jul-24-23 01:46PM	U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation (GlobeNewswire) -12.76%
Jun-29-23 11:24AM	Liquidia (LQDA) Up on Deal With Pharmosa to Co-Develop PH Drug (Zacks) -17.68%
Jun-28-23 05:36AM	Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America (GlobeNewswire) +10.99%
May-31-23 06:30AM	Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference (GlobeNewswire)
May-30-23 11:26AM	Investing in Liquidia (NASDAQ:LQDA) a year ago would have delivered you a 106% gain (Simply Wall St.)
May-21-23 03:39PM	Hero or Zero? 7 High-Risk Stocks to Make You Rich Or Broke. (InvestorPlace)
May-19-23 06:15AM	Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference (GlobeNewswire) +6.14%
May-09-23 06:33AM	Institutional investors are Liquidia Corporation's (NASDAQ:LQDA) biggest bettors and were rewarded after last week's US$60m market cap gain (Simply Wall St.)
May-04-23 09:15AM	Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
May-02-23 06:45AM	Liquidia Corporation to Present at BofA Securities 2023 Health Care Conference (GlobeNewswire)
Apr-27-23 06:45AM	Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023 (GlobeNewswire)
Apr-20-23 04:17AM	Strength Seen in EyePoint Pharmaceuticals (EYPT): Can Its 9.6% Jump Turn into More Strength? (Zacks)
Apr-18-23 08:33AM	Liquidia Corporation's (NASDAQ:LQDA) Earnings Haven't Escaped The Attention Of Investors (Simply Wall St.)
Apr-11-23 06:45AM	Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-03-23 06:45AM	Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications (GlobeNewswire)
Mar-25-23 08:33AM	Industry Analysts Just Made A Captivating Upgrade To Their Liquidia Corporation (NASDAQ:LQDA) Revenue Forecasts (Simply Wall St.)
Mar-20-23 04:10AM	Liquidia Corporation (NASDAQ:LQDA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-18-23 08:34AM	Liquidia Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Mar-17-23 03:22AM	Q4 2022 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-16-23 07:55AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +15.25%
06:30AM	Liquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-09-23 10:00AM	Liquidia Technologies, Inc. (LQDA) May Report Negative Earnings: Know the Trend Ahead of Q4 Release (Zacks) -5.41%
07:19AM	Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023 (GlobeNewswire)
Feb-17-23 07:33AM	Insiders saw their US$2.6m investment bump up to US$4.2m after Liquidia Corporation (NASDAQ:LQDA) soared 15% last week (Simply Wall St.)
Feb-05-23 08:49PM	Decision moves Liquidia, United Therapeutics patent dispute toward resolution (American City Business Journals)
Feb-03-23 05:10AM	Strength Seen in Liquidia Technologies, Inc. (LQDA): Can Its 9.7% Jump Turn into More Strength? (Zacks)
Feb-02-23 04:39PM	Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (793 Patent) (GlobeNewswire) +9.70%
06:30AM	Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-09-23 10:01PM	Liquidia inks $100M financing agreement amid patent dispute (American City Business Journals)
06:30AM	Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million (GlobeNewswire)
Dec-30-22 09:40AM	Are Medical Stocks Lagging Assertio (ASRT) This Year? (Zacks)
Dec-14-22 09:40AM	Are Medical Stocks Lagging Assertio (ASRT) This Year? (Zacks)
Dec-05-22 04:05PM	Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH) (GlobeNewswire) -5.65%
Dec-01-22 09:55AM	Wall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 153%: Read This Before Placing a Bet (Zacks) +5.78%
Nov-28-22 09:40AM	Is Liquidia Technologies (LQDA) Stock Outpacing Its Medical Peers This Year? (Zacks)
Nov-08-22 07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
06:30AM	Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-02-22 10:15AM	ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS (PR Newswire)
Nov-01-22 06:45AM	Liquidia to Report Third Quarter 2022 Financial Results on November 8, 2022 (GlobeNewswire) +5.93%
Oct-27-22 04:10PM	Precedential Opinion Panel Denies United Therapeutics Request for Review of 793 Inter Partes Review Decision (GlobeNewswire)
Oct-26-22 09:40AM	Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year? (Zacks)
Oct-17-22 06:30AM	Liquidia Announces Presentations at the CHEST 2022 Annual Meeting (GlobeNewswire)
Sep-26-22 06:45AM	7 Momentum Stocks to Buy Now for Extraordinary Gains (InvestorPlace)
Sep-10-22 08:24AM	Trade Alert: The CEO & Director Of Liquidia Corporation (NASDAQ:LQDA), Roger Jeffs, Has Just Spent US$244k Buying 2.6% More Shares (Simply Wall St.)
Sep-08-22 11:26AM	Liquidia (NASDAQ:LQDA) Is Using Debt Safely (Simply Wall St.) +5.87%
Sep-06-22 12:15PM	Liquidia faces delay for drug launch after ruling in United Therapeutics case (American City Business Journals)
Sep-02-22 05:58PM	Why Liquidia Stock Rocketed Nearly 21% Higher Today (Motley Fool) +20.58%
Aug-31-22 07:46PM	Liquidia Provides Update on Hatch-Waxman Litigation and to Host Call on September 1, 2022, at 8:00am E.T. (GlobeNewswire) +7.25%
09:55AM	Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 136%: Here's is How to Trade (Zacks)
09:40AM	Is Liquidia Technologies (LQDA) Outperforming Other Medical Stocks This Year? (Zacks)
Aug-23-22 03:09PM	Find Highly-Ranked Cheap Stocks Under $10 to Buy with this Screen (Zacks)
12:00PM	Here's Why Liquidia Technologies, Inc. (LQDA) is a Great Momentum Stock to Buy (Zacks)

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. The company was founded on June 28, 2020, and is headquartered in Morrisville, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saggar Rajeev	Chief Medical Officer	Apr 19 '24	Sale	13.68	1,649	22,558	211,672	Apr 23 05:24 PM
JEFFS ROGER	Chief Executive Officer	Apr 12 '24	Sale	14.58	8,360	121,889	826,985	Apr 16 05:15 PM
Kaseta Michael	CFO and COO	Apr 12 '24	Sale	14.58	3,136	45,723	315,045	Apr 16 05:16 PM
Schundler Russell	General Counsel	Apr 12 '24	Sale	14.58	2,060	30,035	486,027	Apr 16 05:17 PM
Moomaw Scott	Chief Commercial Officer	Apr 12 '24	Sale	14.58	1,585	23,109	151,881	Apr 16 05:16 PM
Saggar Rajeev	Chief Medical Officer	Apr 12 '24	Sale	14.58	1,525	22,234	213,321	Apr 16 05:17 PM
Adair Jason	Chief Business Officer	Apr 12 '24	Sale	14.58	1,189	17,336	111,537	Apr 15 08:31 PM
JEFFS ROGER	Chief Executive Officer	Mar 18 '24	Sale	15.82	28,583	452,183	835,345	Mar 19 09:46 PM
Kaseta Michael	CFO and COO	Mar 18 '24	Sale	15.82	12,166	192,466	318,181	Mar 19 09:47 PM
Schundler Russell	General Counsel	Mar 18 '24	Sale	15.82	8,653	136,890	488,087	Mar 19 09:48 PM
Saggar Rajeev	Chief Medical Officer	Mar 18 '24	Sale	15.82	7,530	119,125	214,846	Mar 19 09:46 PM
Moomaw Scott	Chief Commercial Officer	Mar 18 '24	Sale	15.82	6,108	96,629	153,466	Mar 19 09:47 PM
Adair Jason	Chief Business Officer	Mar 18 '24	Sale	15.81	4,657	73,649	108,640	Mar 19 09:50 PM
Moomaw Scott	Chief Commercial Officer	Feb 29 '24	Sale	14.17	546	7,737	159,574	Mar 04 07:07 PM
Adair Jason	Chief Business Officer	Feb 29 '24	Sale	14.17	455	6,447	97,412	Mar 04 07:05 PM
Adair Jason	Chief Business Officer	Dec 18 '23	Sale	7.70	77	593	54,932	Dec 20 05:20 PM
Caligan Partners LP	Director	Dec 14 '23	Buy	7.16	1,117,318	7,999,997	11,280,945	Dec 14 04:42 PM
Manning Paul B	Director	Dec 14 '23	Buy	7.16	279,330	2,000,003	279,330	Dec 18 05:00 PM
JEFFS ROGER	Chief Executive Officer	Dec 14 '23	Buy	7.16	139,665	1,000,001	640,805	Dec 18 05:02 PM
Moomaw Scott	Chief Commercial Officer	Nov 30 '23	Sale	7.28	542	3,946	106,737	Dec 05 09:18 PM
Lippe Robert A	Chief Operations Officer	Nov 30 '23	Sale	7.28	497	3,618	193,788	Dec 05 09:21 PM
Adair Jason	Chief Business Officer	Nov 30 '23	Sale	7.28	452	3,291	54,478	Dec 05 09:15 PM
Adair Jason	Chief Business Officer	Sep 19 '23	Sale	6.51	75	488	53,637	Sep 20 06:14 PM
Moomaw Scott	Chief Commercial Officer	Aug 31 '23	Sale	6.88	537	3,695	105,404	Sep 05 08:10 PM
Lippe Robert A	Chief Operations Officer	Aug 31 '23	Sale	6.88	505	3,474	192,567	Sep 05 08:11 PM
Adair Jason	Chief Business Officer	Aug 31 '23	Sale	6.88	445	3,062	53,452	Sep 05 08:09 PM
Moomaw Scott	Chief Commercial Officer	May 31 '23	Sale	8.08	651	5,260	102,268	Jun 02 05:05 PM
Lippe Robert A	Chief Operations Officer	May 31 '23	Sale	8.08	597	4,824	189,646	Jun 02 05:03 PM

Open in Screener

CDLX

Cardlytics Inc

Apr 23 • 04:00PM ET

12.37

Dollar change -0.21
Percentage change -1.67	%

Communication Services • Advertising Agencies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF PTF IWN DWAS SCHA VTWO VOX DFAT

Index	RUT	P/E	-	EPS (ttm)	-3.49	Insider Own	6.83%	Shs Outstand	44.11M	Perf Week	-0.32%
Market Cap	545.64M	Forward P/E	-	EPS next Y	-0.85	Insider Trans	31.28%	Shs Float	41.10M	Perf Month	-22.20%
Income	-134.70M	PEG	-	EPS next Q	-0.43	Inst Own	68.24%	Short Float	14.48%	Perf Quarter	96.35%
Sales	309.20M	P/S	1.76	EPS this Y	66.80%	Inst Trans	-0.02%	Short Ratio	3.34	Perf Half Y	5.91%
Book/sh	3.39	P/B	3.65	EPS next Y	30.20%	ROA	-21.29%	Short Interest	5.95M	Perf Year	90.31%
Cash/sh	2.08	P/C	5.94	EPS next 5Y	44.10%	ROE	-77.77%	52W Range	4.94 - 20.52	Perf YTD	34.31%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-5.75%	ROI	-33.78%	52W High	-39.72%	Beta	1.50
Dividend TTM	-	Quick Ratio	1.31	Sales past 5Y	17.35%	Gross Margin	42.74%	52W Low	150.40%	ATR (14)	1.17
Dividend Ex-Date	Aug 05, 2008	Current Ratio	1.31	EPS Y/Y TTM	75.15%	Oper. Margin	-20.59%	RSI (14)	48.80	Volatility	6.07% 9.87%
Employees	434	Debt/Eq	1.97	Sales Y/Y TTM	3.57%	Profit Margin	-43.56%	Recom	1.00	Target Price	17.67
Option/Short	Yes / Yes	LT Debt/Eq	1.96	EPS Q/Q	77.42%	Payout	-	Rel Volume	0.31	Prev Close	12.58
Sales Surprise	-0.43%	EPS Surprise	-923.78%	Sales Q/Q	8.08%	Earnings	Mar 14 AMC	Avg Volume	1.78M	Price	12.37
SMA20	-10.11%	SMA50	14.42%	SMA200	14.10%	Trades		Volume	547,472	Change	-1.67%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-15-24	Upgrade	Craig Hallum	Hold → Buy	$10 → $18
Nov-29-23	Initiated	Lake Street	Buy	$13
Sep-08-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$14 → $13
Jul-14-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$72 → $15
Jul-13-22	Downgrade	BofA Securities	Neutral → Underperform	$14
Jul-12-22	Downgrade	Craig Hallum	Buy → Hold	$50 → $20
Apr-05-22	Resumed	Wells Fargo	Overweight	$72
Jun-18-21	Initiated	Needham	Buy	$135
Apr-15-21	Upgrade	Wells Fargo	Equal Weight → Overweight	$150
Apr-14-21	Upgrade	Craig Hallum	Hold → Buy	$145
Mar-05-21	Upgrade	BofA Securities	Underperform → Neutral	$128
Jan-14-21	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-20	Downgrade	Wells Fargo	Overweight → Equal Weight	$80
Apr-21-20	Downgrade	BofA/Merrill	Buy → Underperform
Mar-04-20	Downgrade	Craig Hallum	Buy → Hold	$100 → $70
Jan-15-20	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-02-19	Initiated	Craig Hallum	Buy
Nov-14-19	Downgrade	JP Morgan	Overweight → Neutral	$58
Aug-09-19	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jul-24-19	Reiterated	BofA/Merrill	Buy	$22 → $32

Show Previous Ratings

Apr-15-24 09:30AM	5 Tech Stocks for Less Than $50 for April 2024 (Investopedia)
Apr-09-24 04:02PM	Liane Hornsey Appointed to Cardlytics Board of Directors (GlobeNewswire)
Apr-03-24 01:52AM	Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares (GuruFocus.com)
01:52AM	Cardlytics Inc (CDLX) Chief Legal & Privacy Officer Nicholas Lynton Sells 12,460 Shares (GuruFocus.com)
Apr-02-24 05:53PM	Why Cardlytics Stock Skyrocketed 75% Last Month (Motley Fool) -5.60%
09:15PM	Loading…
Mar-26-24 09:15PM	Cardlytics Prices $150.0 Million Convertible Senior Notes Offering (GlobeNewswire) -32.84%
06:41PM	Why Cardlytics Stock Tanked by 33% Today (Motley Fool)
07:13AM	Cardlytics Announces Proposed Convertible Senior Notes Offering (GlobeNewswire)
Mar-22-24 09:54PM	NYCB, Vista Outdoor, Cardlytics, and More Stocks See Action From Activist Investors (Barrons.com)
Mar-19-24 02:37PM	Hedge Fund and Insider Trading News: Crispin Odey, John Paulson, Ken Griffin, Daniel Loeb, Steve Cohen, Nelson Peltz, Millennium Management, L3Harris Technologies Inc (LHX), Cardlytics, Inc. (CDLX), and More (Insider Monkey) +7.96%
Mar-15-24 01:22PM	Cardlytics, Inc. (NASDAQ:CDLX) Q4 2023 Earnings Call Transcript (Insider Monkey) +77.15%
11:42AM	Here's Why Cardlytics Stock Absolutely Skyrocketed Today (Motley Fool)
08:52AM	Q4 2023 Cardlytics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 05:34PM	Cardlytics Inc (CDLX) Reports Growth in Revenue and Adjusted EBITDA for Q4 and Full Year 2023 (GuruFocus.com)
04:43PM	Cardlytics: Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	Loading…
04:03PM	Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-08-24 04:05PM	Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +6.87%
Feb-29-24 04:05PM	Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast (GlobeNewswire)
Jan-29-24 11:16AM	Why Cardlytics Stock Skyrocketed Today (Motley Fool) +24.61%
07:56AM	Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results (GlobeNewswire)
Jan-24-24 11:02PM	Cardlytics Inc COO Amit Gupta Sells 72,658 Shares (GuruFocus.com)
Jan-04-24 11:02AM	Cardlytics Inc CEO Karim Temsamani Sells 31,123 Shares (GuruFocus.com) -5.32%
Jan-02-24 04:05PM	Cardlytics Appoints Two New Members to its Board of Directors (GlobeNewswire)
Dec-19-23 07:30AM	Cardlytics Announces Multi-Year Contract Renewal with Lloyds Bank Plc (GlobeNewswire) +7.30%
Dec-12-23 08:00AM	Kigo, an Augeo subsidiary, acquires Entertainment to advance Open Loyalty innovation & elevate digital offer experiences (PR Newswire)
Dec-06-23 08:58PM	Insider Sell Alert: CEO Karim Temsamani Unloads Shares of Cardlytics Inc (GuruFocus.com)
Nov-09-23 02:30PM	Cardlytics, Inc. (NASDAQ:CDLX) Q3 2023 Earnings Call Transcript (Insider Monkey) -54.45%
Nov-08-23 05:53PM	Cardlytics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Cardlytics Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-27-23 05:09PM	Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:30AM	Loading…
Oct-26-23 08:30AM	Cardlytics Announces Timing of Its Third Quarter 2023 Financial Results Conference Call and Webcast (GlobeNewswire)
Oct-04-23 07:01AM	Insider Sell: Nicholas Lynton Sells 12,751 Shares of Cardlytics Inc (CDLX) (GuruFocus.com)
Sep-28-23 04:21PM	15 Recent Activist Investor Campaigns (Insider Monkey) +7.33%
03:28PM	This Hedge Fund is Up 88% This Year, Here is What Its Buying (Insider Monkey)
Sep-22-23 06:40PM	Cardlytics, Immunocore, and More Stocks See Action From Activist Investors (Barrons.com)
Sep-19-23 04:05PM	Cardlytics Appoints Alex Mishurov to its Board of Directors (GlobeNewswire)
Sep-12-23 05:01AM	Insider Sell: Cardlytics Inc CEO Karim Temsamani Sells 166,973 Shares (GuruFocus.com)
Sep-06-23 04:05PM	Finance Veteran Scott A. Hill appointed to Cardlytics Board of Directors (GlobeNewswire)
Aug-17-23 09:00AM	Bridg Launches Rippl Data and Media Network (GlobeNewswire)
Aug-03-23 08:08AM	Cardlytics, Inc. (NASDAQ:CDLX) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-02-23 09:03AM	Q2 2023 Cardlytics Inc Earnings Call (Thomson Reuters StreetEvents) +19.79%
Aug-01-23 05:25PM	Cardlytics (CDLX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:19PM	Cardlytics: Q2 Earnings Snapshot (AP Finance)
04:05PM	Cardlytics Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-20-23 04:05PM	Cardlytics Announces Timing of Its Second Quarter 2023 Financial Results Conference Call and Webcast (GlobeNewswire) -12.60%
Jul-19-23 03:10PM	Cardlytics names new CFO months after leadership shakeup (American City Business Journals)
Jul-18-23 08:00AM	Cardlytics Appoints New Chief Financial Officer (GlobeNewswire) +9.50%
08:00AM	Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-14-23 03:56PM	Cardlytics (CDLX) Surges 13.2%: Is This an Indication of Further Gains? (Zacks) -6.56%
Jul-12-23 07:39AM	Cardlytics (NASDAQ:CDLX) shareholders are up 38% this past week, but still in the red over the last three years (Simply Wall St.) +8.16%
Jul-06-23 03:11PM	CleanSpark (CLSK) Soars 8.6%: Is Further Upside Left in the Stock? (Zacks)
Jun-30-23 06:39PM	Cardlytics and Motorcar Parts of America Stock See Action From Activist Investors (Barrons.com)
Jun-19-23 09:40AM	Is Cardlytics (CDLX) Stock Outpacing Its Business Services Peers This Year? (Zacks)
Jun-08-23 06:53AM	Cardlytics, Inc. (NASDAQ:CDLX) is largely controlled by institutional shareholders who own 67% of the company (Simply Wall St.)
May-08-23 09:55AM	Does Cardlytics (CDLX) Have the Potential to Rally 49.25% as Wall Street Analysts Expect? (Zacks)
May-05-23 10:14AM	Q1 2023 Cardlytics Inc Earnings Call (Thomson Reuters StreetEvents) -27.26%
May-04-23 06:35PM	Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:34PM	Cardlytics: Q1 Earnings Snapshot (AP Finance)
04:05PM	Cardlytics Announces First Quarter 2023 Financial Results (GlobeNewswire)
May-02-23 09:30AM	Cardlytics (CDLX) Recently Broke Out Above the 200-Day Moving Average (Zacks)
May-01-23 07:35AM	Cardlytics Announces Update to Bridg Earnout Payments (GlobeNewswire) +27.27%
Apr-27-23 05:15PM	Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +6.40%
10:02AM	Earnings Preview: NV5 Global (NVEE) Q1 Earnings Expected to Decline (Zacks)
Apr-24-23 04:21PM	Cardlytics Announces Timing of Its First Quarter 2023 Financial Results Conference Call and Webcast (GlobeNewswire) -6.77%
10:00AM	Analysts Estimate Cardlytics (CDLX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-05-23 06:23PM	Cardlytics (CDLX) Soars 80.9%: Is Further Upside Left in the Stock? (Zacks) -22.44%
Apr-04-23 07:30AM	Cardlytics Announces Updated Guidance for First Quarter 2023 Financial Results (GlobeNewswire) +80.87%
Mar-22-23 04:05PM	Cardlytics Announces CFO Transition (GlobeNewswire) -15.19%
Mar-20-23 08:13PM	Strength Seen in Symbotic Inc. (SYM): Can Its 9.5% Jump Turn into More Strength? (Zacks)
Mar-14-23 04:21PM	Cardlytics Announces Partial Drawdown of Line of Credit in Response to Uncertainty in the Financial Sector (GlobeNewswire)
Mar-04-23 07:23AM	Cardlytics Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Mar-03-23 05:46AM	Cardlytics, Inc. (NASDAQ:CDLX) Shares Could Be 38% Below Their Intrinsic Value Estimate (Simply Wall St.)
Mar-02-23 11:08AM	Q4 2022 Cardlytics Inc Earnings Call (Thomson Reuters StreetEvents) -8.65%
Mar-01-23 05:55PM	Cardlytics (CDLX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:58PM	Cardlytics: Q4 Earnings Snapshot (AP Finance)
04:05PM	Cardlytics Announces Fourth Quarter and Fiscal Year 2022 Financial Results (GlobeNewswire)
Feb-19-23 03:36PM	12 Stocks To Sell According to Motley Fool (Insider Monkey)
Feb-16-23 04:05PM	Cardlytics Announces Timing of Its Fourth Quarter 2022 Financial Results Conference Call and Webcast (GlobeNewswire)
Jan-30-23 03:21PM	Strength Seen in Cardlytics (CDLX): Can Its 12.1% Jump Turn into More Strength? (Zacks)
Jan-24-23 07:49AM	Cardlytics names new C-suite executive months after layoffs (American City Business Journals)
Jan-23-23 04:05PM	Cardlytics Appoints Amit Gupta as Chief Operating Officer (GlobeNewswire)
04:05PM	Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-01-22 04:05PM	Cardlytics to Present at the 2022 Raymond James Technology Investors Conference (GlobeNewswire)
Nov-29-22 04:57PM	Cardlytics co-founder takes role at Atlanta venture firm after resignation (American City Business Journals) +5.54%
Nov-17-22 03:27PM	Cardlytics founders resign amid company layoffs (American City Business Journals)
Nov-09-22 09:55AM	Here's Why Cardlytics (CDLX) Is a Great 'Buy the Bottom' Stock Now (Zacks) -10.27%
Nov-08-22 09:35AM	After Plunging 52% in 4 Weeks, Here's Why the Trend Might Reverse for Cardlytics (CDLX) (Zacks)
Nov-02-22 04:16PM	Cardlytics stock cut in half amid 'continued uncertainty' from advertisers (MarketWatch) -53.41%
02:15PM	Here's Why Cardlytics Stock Sank to an All-Time Low on Wednesday (Motley Fool)
01:39PM	Cardlytics Sees Price Target Cut By 26% To Reflect Macro Headwinds (Benzinga)
Nov-01-22 05:35PM	Cardlytics (CDLX) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Cardlytics Announces Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-19-22 04:05PM	Cardlytics Announces Timing of Its Third Quarter 2022 Financial Results Conference Call and Webcast (GlobeNewswire)
Oct-10-22 07:48AM	Shareholders in Cardlytics (NASDAQ:CDLX) are in the red if they invested a year ago (Simply Wall St.)
Sep-19-22 04:38PM	10 Best Stocks to Buy According to Ari Zweimans 683 Capital Partners (Insider Monkey)
Sep-01-22 08:30AM	Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.06%
Aug-02-22 11:30PM	Cardlytics, Inc. (CDLX) Q2 2022 Earnings Call Transcript (Motley Fool) +10.81%
05:35PM	Cardlytics (CDLX) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Cardlytics Announces Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-01-22 10:00AM	Cardlytics Back-to-School Trend Analysis Shows Impact of Omnichannel on Consumer Spend and Retention (GlobeNewswire)

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Apr 23 '24	Sale	12.76	276	3,521	71,761	Apr 23 07:03 PM
Temsamani Karim Saad	Chief Executive Officer	Apr 02 '24	Sale	13.69	32,564	445,801	344,734	Apr 02 08:22 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Apr 02 '24	Sale	13.69	12,460	170,620	71,355	Apr 02 08:23 PM
Temsamani Karim Saad	Chief Executive Officer	Apr 01 '24	Sale	14.41	154	2,219	344,580	Apr 02 08:22 PM
SOSIN CLIFFORD	10% Owner	Mar 19 '24	Buy	14.16	350,000	4,956,035	6,373,676	Mar 21 07:34 PM
SOSIN CLIFFORD	10% Owner	Mar 18 '24	Buy	13.40	350,000	4,689,685	6,023,676	Mar 18 07:48 PM
SOSIN CLIFFORD	10% Owner	Mar 15 '24	Buy	13.71	311,715	4,274,174	5,673,676	Mar 18 07:48 PM
Temsamani Karim Saad	Chief Executive Officer	Mar 04 '24	Sale	7.89	34,515	272,323	327,298	Mar 05 04:24 PM
Gupta Amit	Chief Operating Officer	Jan 24 '24	Sale	6.10	72,658	443,286	102,342	Jan 24 06:21 PM
Gupta Amit	Chief Operating Officer	Jan 23 '24	Option Exercise	0.00	175,000	0	175,000	Jan 24 06:21 PM
SOSIN CLIFFORD	10% Owner	Jan 12 '24	Sale	7.00	17,155	120,128	5,361,961	Jan 16 04:30 PM
Temsamani Karim Saad	Chief Executive Officer	Jan 03 '24	Sale	7.77	31,123	241,826	277,735	Jan 03 08:00 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Jan 03 '24	Sale	7.77	15,620	121,367	55,849	Jan 03 07:59 PM
SOSIN CLIFFORD	10% Owner	Jan 02 '24	Sale	8.86	37,000	327,698	5,379,116	Jan 04 04:20 PM
Temsamani Karim Saad	Chief Executive Officer	Dec 05 '23	Sale	8.21	40,413	331,791	258,858	Dec 05 07:53 PM
Temsamani Karim Saad	Chief Executive Officer	Dec 01 '23	Option Exercise	0.00	84,079	0	299,271	Dec 05 07:53 PM
Temsamani Karim Saad	Chief Executive Officer	Oct 02 '23	Sale	14.31	28,576	408,993	215,192	Oct 03 06:27 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Oct 02 '23	Sale	14.31	12,751	182,498	44,310	Oct 03 06:27 PM
Temsamani Karim Saad	Chief Executive Officer	Sep 08 '23	Sale	17.71	81,542	1,444,027	193,768	Sep 11 04:02 PM
Temsamani Karim Saad	Chief Executive Officer	Sep 07 '23	Sale	16.90	85,431	1,444,040	275,310	Sep 11 04:02 PM
Temsamani Karim Saad	Chief Executive Officer	Sep 01 '23	Option Exercise	0.00	336,315	0	360,741	Sep 05 04:05 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Aug 09 '23	Sale	13.67	7,500	102,525	29,486	Aug 09 04:45 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Aug 07 '23	Sale	13.50	5,122	69,139	36,986	Aug 09 04:45 PM
Christiansen Andrew	Chief Financial Officer	Jul 19 '23	Sale	10.20	13,404	136,721	70,775	Jul 20 04:10 PM
Christiansen Andrew	Chief Financial Officer	Jul 18 '23	Option Exercise	0.00	30,147	0	84,179	Jul 20 04:10 PM
Temsamani Karim Saad	Chief Executive Officer	Jul 03 '23	Sale	6.13	25,574	156,666	24,426	Jul 05 06:39 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Jul 03 '23	Sale	6.13	9,906	60,684	42,108	Jul 05 07:48 PM
Temsamani Karim Saad	Chief Executive Officer	Jul 01 '23	Option Exercise	0.00	50,000	0	50,000	Jul 05 06:39 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Jul 01 '23	Option Exercise	0.00	31,892	0	52,014	Jul 05 07:48 PM
Christiansen Andrew	Chief Financial Officer	Jun 23 '23	Sale	5.68	649	3,686	54,032	Jun 26 06:31 PM
Christiansen Andrew	Chief Financial Officer	Jun 22 '23	Option Exercise	0.00	2,034	0	54,681	Jun 26 06:31 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

LQDA

Liquidia Corp

CDLX

Cardlytics Inc

Upgrade your FINVIZ experience